CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-05 | O'Keefe Kenneth W Director | Sale | −1,746 | $155.14 | $271K | 23,180 |
| 2020-11-05 | O'Keefe Kenneth W Director | Sale | −4,513 | $156.44 | $706K | 18,667 |
| 2020-11-04 | Sohn Catherine A. Director | Option exercise | +4,500 | $81.76 | $368K | 15,122 |
| 2020-11-04 | Sohn Catherine A. Director | Sale | −4,500 | $156.00 | $702K | 10,622 |
| 2020-11-04 | Sohn Catherine A. Director | Option exercise | +8,000 | $46.83 | $375K | 18,622 |
| 2020-11-04 | Sohn Catherine A. Director | Sale | −8,000 | $152.00 | $1.2M | 10,622 |
| 2020-11-04 | Sohn Catherine A. Director | Option exercise · Non-Qualified Stock Option (right to buy) | −8,000 | 0 | ||
| 2020-11-04 | Sohn Catherine A. Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2020-11-04 | BERNS PAUL L Director | Sale | −466 | $147.44 | $69K | 13,965 |
| 2020-11-04 | BERNS PAUL L Director | Sale | −400 | $149.28 | $60K | 13,565 |
| 2020-11-04 | BERNS PAUL L Director | Sale | −3,825 | $150.90 | $577K | 9,740 |
| 2020-11-03 | COZADD BRUCE C Chairman & CEO | Sale | −2,500 | $154.00 | $385K | 328,680 |
| 2020-11-02 | BERNS PAUL L Director | Option exercise | +4,691 | 14,431 | ||
| 2020-11-02 | BERNS PAUL L Director | Option exercise · Phantom Stock | −4,691 | 0 | ||
| 2020-11-02 | O'Keefe Kenneth W Director | Option exercise | +22,249 | 29,667 | ||
| 2020-11-02 | O'Keefe Kenneth W Director | Option exercise · Phantom Stock | −22,249 | 0 | ||
| 2020-11-02 | ENRIGHT PATRICK G Director | Option exercise | +9,929 | 30,297 | ||
| 2020-11-02 | ENRIGHT PATRICK G Director | Option exercise · Phantom Stock | −9,929 | 0 | ||
| 2020-11-02 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $145.13 | $145K | 331,180 |
| 2020-10-01 | COZADD BRUCE C Chairman & CEO | Sale | −4,500 | $141.94 | $639K | 332,180 |
Page 35 of 39 · 780 trades